Ekso Bionics Holdings, Inc. Annual report pursuant to Section 13 and 15(d)

Segment Disclosures (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
Segment Disclosures (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Segment Reporting Information [Line Items]
Revenue	$ 2,453	$ 1,597	$ 1,867	$ 1,436	$ 2,587	$ 1,596	$ 1,552	$ 8,486	$ 7,353	$ 14,221	$ 8,661
Cost of revenue									5,284	11,274	7,482
Gross profit	$ 777	$ 544	$ 396	$ 352	$ 843	$ 403	$ 203	$ 1,498	2,069	2,947	1,179
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue									7,315	13,434	4,352
Cost of revenue									5,270	10,715	3,926
Gross profit									2,045	2,719	426
Medical [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue									5,831	12,181	4,352
Cost of revenue									4,164	9,767	3,926
Gross profit									1,667	2,414	426
Engineering Services [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue									38	787	4,309
Cost of revenue									14	559	3,556
Gross profit									24	228	753
Industrial [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue									1,484	1,253	0
Cost of revenue									1,106	948	0
Gross profit									$ 378	$ 305	$ 0